The AB Ultra Short Income ETF (YEAR) is gaining attention as a low-risk, ultra-short bond ETF with an effective duration under one year and a 30-day SEC yield of 3.98%. With expectations of potential Federal Reserve rate cuts in 2026, YEAR offers a conservative alternative to cash and money market funds, which may see declining yields. This ETF provides daily liquidity, capital preservation, and diversification, making it a preferred choice for investors seeking income without high volatility. As $8 trillion remains in money markets, YEAR could attract risk-averse investors looking for better returns while maintaining safety.
Donaldson reported record third-quarter sales of $995.1 million, up 5.8% year-over-year, surpassing analyst expectations. Adjusted earnings per share were $1.06, slightly above estimates, despite a small margin decline due to operational inefficienci...
NASB Financial, Inc. announced a quarterly cash dividend of $0.35 per share, payable on June 26, 2026, to shareholders of record as of June 12, 2026. This dividend reflects NASB's ongoing commitment to returning value to its investors. NASB Financial...
Gilead Sciences announced positive Phase 3 IDEAL study results for Livdelzi (seladelpar) in treating primary biliary cholangitis (PBC). The drug significantly normalized alkaline phosphatase (ALP), a critical liver disease marker, in patients with in...
The global Legal Technology market, valued at $26.5 billion in 2024, is projected to grow to $71.9 billion by 2034 at a 10.5% CAGR. Growth is fueled by increasing regulatory complexity, adoption of AI and cloud-based solutions, and the shift to remot...
More than 25 companies are actively developing over 30 drugs for myasthenia gravis, a chronic autoimmune disorder causing muscle weakness. Key therapies in late-stage trials include targeted biologics like Immunoglobulin G degraders and Complement fa...
